The process is the same as any other peptide, but MOTS-C has a unique consideration: the doses are relatively large (5-10mg) compared to peptides like BPC-157 or semaglutide, which means the dilution choice matters more for injection volume
Some weeks the scale will go up
A treatment-related increase in benign thyroid C-cell adenomas was seen in males in 0.25 and 0.75 mg/kg/day liraglutide groups with incidences of 12%, 16%, 42%, and 46% and in all female liraglutide-treated groups with incidences of 10%, 27%, 33%, and 56% in 0 (control), 0.075, 0.25, and 0.75 mg/kg/day groups, respectively
The report covers an in-depth analysis of 40+ countries top-performing countries are highlighted below